The Jinling Cohort

Recruiting Observational Study
Cancer Multi Cancer Early Screening Liquid Biopsy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 75
Sex
Any
Study type
Observational
Participants needed
15,000 (estimated)
Sponsor
Nanjing Shihejiyin Technology, Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1、45-75 years of age; 2、Willing and able to undergo blood sample collection, health questionnaires and annual routine physical exams once a year for three consecutive years; 3、Residents in Nanjing; 4、Fully understand the study and able to provide a written informed consent Excl…
Contacts

Shanshan Yang, Ph.D

8613585145836

admin@geneseeq.com

CONTACT

Xuan Wang

8618392411194

cohortstudy@geneseeq.com

CONTACT